Global Laboratory Network

Global Laboratory Network
Name	Global Laboratory Network
Caption	International laboratory collaboration schematic
Formation	20th century
Type	International network
Headquarters	Geneva
Region served	Worldwide
Membership	National reference laboratories, supranational institutes, university laboratories, private diagnostic companies
Languages	English, French

Contents

Global Laboratory Network The Global Laboratory Network is an international collaboration linking national reference centers, supranational institutes, university laboratories, and private diagnostic companies to coordinate World Health Organization initiatives, support Centers for Disease Control and Prevention programs, and harmonize laboratory responses to transnational threats such as COVID-19 pandemic, Ebola virus epidemic in West Africa, and Zika virus outbreak. It convenes stakeholders including the European Centre for Disease Prevention and Control, Pan American Health Organization, African Union health organs, and academic partners like Johns Hopkins University, University of Oxford, and Harvard University to advance diagnostic capacity, surveillance, and research.

Overview

The network integrates national reference laboratories such as Public Health England labs, the Robert Koch Institute, and the Institut Pasteur system with supranational organizations including the World Health Organization Regional Office for Europe, Africa Centres for Disease Control and Prevention, and the European Commission scientific services to provide coordinated laboratory support during outbreaks like the H1N1 2009 pandemic, SARS epidemic, and incidents assessed by the Global Outbreak Alert and Response Network. It draws membership from academic institutions such as University of California, San Francisco, Karolinska Institutet, and National University of Singapore, as well as private firms including Roche Diagnostics, Abbott Laboratories, and Cepheid.

Origins trace to efforts by the World Health Organization and the Pan American Health Organization after the Smallpox eradication campaign and during expansion of the International Health Regulations (2005), with early coordination involving the Centers for Disease Control and Prevention and the UK Public Health Laboratory Service. The network expanded through initiatives led by organizations such as the Bill & Melinda Gates Foundation, collaborations with Médecins Sans Frontières, and technical partnerships with the European Centre for Disease Prevention and Control. Major milestones include responses to SARS-CoV-1 outbreak, establishment of platforms promoted by the Global Fund to Fight AIDS, Tuberculosis and Malaria, and integration with research consortia like the Coalition for Epidemic Preparedness Innovations.

Governance typically involves steering committees composed of representatives from the World Health Organization, regional bodies like the Pan American Health Organization, national agencies including the Centers for Disease Control and Prevention and National Institutes of Health, academic partners such as Imperial College London and Massachusetts Institute of Technology, and industry stakeholders like Thermo Fisher Scientific. Operational hubs are often hosted by institutions such as the Institut Pasteur, Robert Koch Institute, and Shanghai CDC, while advisory groups include experts from London School of Hygiene & Tropical Medicine, Johns Hopkins Bloomberg School of Public Health, and the Wellcome Trust. Funding and policy direction are informed by donors like the Bill & Melinda Gates Foundation, multilateral lenders such as the World Bank, and regulatory frameworks influenced by the International Health Regulations.

Primary functions include diagnostic assay validation with partners such as Centers for Disease Control and Prevention laboratories, genomic surveillance collaborations with Wellcome Sanger Institute and Broad Institute, proficiency testing coordinated with College of American Pathologists, and reagent sharing facilitated through links to PATH and Global Fund. Services span training programs run with universities like University of Toronto and McGill University, supply chain coordination with organizations such as UNICEF and Gavi, the Vaccine Alliance, data sharing via platforms developed by Nextstrain and GISAID, and technical guidance produced alongside European Centre for Disease Prevention and Control and World Health Organization.

Quality assurance frameworks rely on standards promulgated by bodies such as the International Organization for Standardization, accreditation by entities like the College of American Pathologists and Joint Commission International, and benchmarking against reference centers including Centers for Disease Control and Prevention and Institut Pasteur reference laboratories. External quality assessment schemes are run in collaboration with organizations like WHO External Quality Assessment Service and the African Society for Laboratory Medicine, with methodological guidance informed by the European Committee for Standardization and regulatory input from the Food and Drug Administration and European Medicines Agency for diagnostics.

During crises the network has supported outbreak investigation teams deployed by World Health Organization and Médecins Sans Frontières, provided surge laboratory capacity for responses to the Ebola virus epidemic in West Africa, assisted national programs during the COVID-19 pandemic with RT-PCR and serology scale-up in partnership with Centers for Disease Control and Prevention, and contributed genomic sequencing to consortia led by Wellcome Sanger Institute and GISAID. It interfaces with emergency financing mechanisms such as the Global Fund and World Bank Pandemic Emergency Financing Facility and works alongside agencies including UNICEF and United Nations emergency operations.

Ongoing challenges include reagent shortages highlighted during the COVID-19 pandemic, equitable data sharing disputes seen in discussions involving GISAID and national governments, workforce shortages noted by institutions like the London School of Hygiene & Tropical Medicine and Johns Hopkins University, and governance complexities involving stakeholders such as the World Health Organization, World Bank, and philanthropic donors like the Bill & Melinda Gates Foundation. Future directions emphasize expansion of genomic surveillance with partners such as the Wellcome Sanger Institute and Broad Institute, integration with digital health platforms promoted by WHO Digital Health Unit, capacity building in concert with the African Union and Pan American Health Organization, and policy reforms aligned with the International Health Regulations (2005) and proposals emerging from the World Health Assembly.

Category:International medical organizations